UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016522
Receipt number R000019186
Scientific Title Survey of Medical Cost and Livelihood of CML Patients
Date of disclosure of the study information 2015/02/12
Last modified on 2015/11/30 14:52:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Survey of Medical Cost and Livelihood of CML Patients

Acronym

Survey of Medical Cost and Livelihood of CML Patients

Scientific Title

Survey of Medical Cost and Livelihood of CML Patients

Scientific Title:Acronym

Survey of Medical Cost and Livelihood of CML Patients

Region

Japan


Condition

Condition

CML

Classification by specialty

Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Investigation of burden and anxiety for the future of health care costs

Basic objectives2

Others

Basic objectives -Others

Measurement of utility for CML patients

Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Investigation of burden and anxiety for the future of health care costs

Key secondary outcomes

QOL of CML patients, percentage of income and medical expenses, drug compliance


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) received medical treatment
(2) under drug therapy, or a drug treatment experience.
(3) received a description of the research
(4) more than three years from the start of treatment.

Key exclusion criteria

(1) do not use of the high-cost medical care system.
(2) being welfare certification

Target sample size



Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yasuo OHASHI

Organization

Chuo University

Division name

Department of Integrated Science and Engineering for Sustainable Society

Zip code


Address

Kasuga Bunkyo-ku TOKYO

TEL

03-3817-1715

Email

ohashiy.00e@g.chuo-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Akira NIWA

Organization

Nonprofit Organization, Japan Clinical Research Support Unit

Division name

Health Outcome Research Promotion Team

Zip code


Address

Sotokanda Chiyoda-ku TOKYO

TEL

03-3254-8028

Homepage URL


Email

niwa@crsu.org


Sponsor or person

Institute

Nonprofit Organization, Japan Clinical Research Support Unit

Institute

Department

Personal name



Funding Source

Organization

Nonprofit Organization, TSUBASA

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

近畿大学(大阪府)、NTT東日本関東病院(東京都)、藤沢市民病院(神奈川県)、大阪市大(大阪府)、札幌北楡病院(北海道)、長崎大学(長崎県)


Other administrative information

Date of disclosure of the study information

2015 Year 02 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2014 Year 10 Month 22 Day

Date of IRB


Anticipated trial start date

2015 Year 02 Month 12 Day

Last follow-up date

2015 Year 06 Month 30 Day

Date of closure to data entry

2015 Year 09 Month 30 Day

Date trial data considered complete

2015 Year 12 Month 31 Day

Date analysis concluded

2016 Year 03 Month 31 Day


Other

Other related information

Survey for CML Patients


Management information

Registered date

2015 Year 02 Month 12 Day

Last modified on

2015 Year 11 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019186


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name